TaiGen Biotechnology Co., Ltd. | Board of Directors

Overview Business Model Steering Committee Board of Directors Management

Latest News

TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints
2010/03/12
More»

TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
2009/12/07
More»

Excellent Stem Cell Mobilization and Safety Profile for TG-0054
2009/09/28
More»

TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing
2009/01/20
More»

TaiGen Announces Presentation of Nemonoxacin at the Joint Meeting of ICAAC/IDSA
2008/10/20
More»

TaiGen Announces Positive Data From the Phase II Study of Nemonoxacin (TG-873870) in Community-Acquired Pneumonia
2008/04/07
More»

Ming-Chu Hsu, Ph.D.
Chairman

Michael Steinmetz, Ph.D.
Director
MPM Bioventures II-QP, L.P.

Show Chung Ho
Director
Hsinex International Corporation

Hong-Jen Chang
Director
Yuen Foong Yu Paper Mfg. Co., Ltd.

Chei-Hsiang Chen
Director
National Development Fund, Executive Yuan

Fu-Shiow Yin
Director
Yao-Hwa Glass Co., Ltd, Management Commission

Steve Lee
Director
China Steel Corporation

Jack Lief
Director
Arena Pharmaceuticals Inc.

Kuo-Hsi Wang
Director
Taiwan Sugar Corporation

Top